Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2D6 genotype-based dosing study for metoprolol and carvedilol
2004-002754-62Phase 4Completed
- Sponsor
- Georg-August-Universität Göttingen
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Cormet and carvedilol (2 arms), sponsored by Georg-August-Universität Göttingen. Primary endpoint: Hepatic metoprolol clearance. Started Oct 2004; status: completed.
02
Drugs
Cormetcarvedilol
Beyond the preview
Go deeper on 2004-002754-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002754-62.